JLGPX
Price
$78.87
Change
+$0.67 (+0.86%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

JLGPX vs VIGIX

Header iconJLGPX vs VIGIX Comparison
Open Charts JLGPX vs VIGIXBanner chart's image
JPMorgan Large Cap Growth R3
Price$78.87
Change+$0.67 (+0.86%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
JLGPX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLGPX vs. VIGIX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGPX is a StrongBuy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. JLGPX (105B). VIGIX pays higher dividends than JLGPX: VIGIX (0.53) vs JLGPX (0.05). JLGPX was incepted earlier than VIGIX: JLGPX (8 years) vs VIGIX (27 years). JLGPX is a more actively managed with annual turnover of: 42.00 vs. VIGIX (5.00). JLGPX has a lower initial minimum investment than VIGIX: JLGPX (0) vs VIGIX (5000000). VIGIX (34.37) and JLGPX (34.04) have marching annual gain over last year. VIGIX return over 5 years is better than : 129.76 vs. JLGPX (96.72).
JLGPXVIGIXJLGPX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD33.88234.27299%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets105B282B37%
Annual Yield % from dividends0.050.539%
Returns for 1 year34.0434.3799%
Returns for 3 years32.5132.7799%
Returns for 5 years96.72129.7675%
Returns for 10 yearsN/A298.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPTT0.340.02
+7.74%
Ocean Power Technologies
CRBG29.660.57
+1.96%
Corebridge Financial
XBIT6.380.04
+0.63%
XBiotech
MLTX52.170.29
+0.56%
MoonLake Immunotherapeutics
EOLS10.890.02
+0.18%
Evolus